What is the role of soluble transferrin receptor (sTfR) in diagnosing and managing iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Soluble Transferrin Receptor (sTfR) in Iron Deficiency Anemia

Soluble transferrin receptor is a highly valuable diagnostic marker for identifying iron deficiency, particularly when inflammation makes ferritin unreliable, and the sTfR/log ferritin ratio provides superior discrimination in distinguishing iron deficiency anemia from anemia of chronic disease. 1

Primary Diagnostic Role

sTfR is most useful when ferritin is equivocal due to concurrent inflammation or chronic disease. 1 In otherwise healthy subjects, sTfR concentration is a good marker of iron deficiency, but serum ferritin remains the first-line test when inflammation is absent. 1

Key Diagnostic Characteristics

  • sTfR levels are elevated in iron deficiency anemia but remain normal or low in anemia of chronic disease alone, making it excellent for differentiation between these conditions. 2

  • sTfR is not affected by inflammation, unlike ferritin which is an acute phase protein and can be falsely elevated despite true iron deficiency. 1, 2

  • In iron deficiency anemia, sTfR concentrations range from 5.3-9.7 mg/L compared to 1.6-3.0 mg/L in anemia of chronic disease or healthy controls. 3, 4, 5

Clinical Decision Algorithm

When to Use sTfR

Order sTfR testing when:

  • Ferritin is 30-100 μg/L with transferrin saturation <16% in the presence of inflammation. 2
  • Ferritin is >100 μg/L with transferrin saturation <16% in inflammatory states to identify concurrent iron deficiency. 2
  • Chronic inflammatory conditions (rheumatologic disease, inflammatory bowel disease, heart failure) coexist with suspected iron deficiency. 1, 2

Do not routinely order sTfR when:

  • Ferritin is <15 μg/L (specificity 0.99 for iron deficiency without sTfR). 1
  • No inflammatory markers are present and ferritin <30 μg/L with transferrin saturation <16%. 2

The sTfR/Log Ferritin Ratio

The [sTfR/log₁₀ ferritin] ratio provides superior discrimination compared to either test alone, particularly in chronic disease. 1

  • A ratio >1.30 indicates iron deficiency anemia or combined iron deficiency with anemia of chronic disease. 3
  • A ratio <0.90 indicates isolated anemia of chronic disease without iron deficiency. 3
  • This ratio has diagnostic efficiency of 0.820 compared to 0.884 for sTfR alone and only 0.638 for ferritin alone. 3

Specific Clinical Scenarios

Inflammatory Bowel Disease

  • In ulcerative colitis patients, sTfR determination helps make correct diagnosis when iron deficiency and anemia of chronic disease coexist. 2
  • When inflammation is present (elevated CRP, leukocytosis), sTfR distinguishes true iron deficiency from anemia of chronic inflammation. 2

Heart Failure

  • sTfR is included in diagnostic algorithms for evaluating iron deficiency in congestive heart failure patients, where anemia significantly impacts mortality and hospitalization. 2
  • sTfR measurement identifies patients who would benefit from intravenous iron therapy even when ferritin levels are inconclusive. 2

Cystic Fibrosis

  • sTfR is the most accurate measure of iron level in CF patients because it is not affected by chronic infection and inflammation. 1
  • Annual monitoring is recommended, though the test is not widely available. 1

Important Caveats

Conditions That Elevate sTfR Beyond Iron Deficiency

sTfR can be falsely elevated in conditions with increased erythropoietic drive, including:

  • Hemolytic anemias 1
  • Thalassemias 1
  • Hemoglobin E disease 1

These conditions must be excluded (via hemoglobin electrophoresis if microcytosis with normal iron studies) before interpreting elevated sTfR as iron deficiency. 1

Test Availability

  • Most UK hospitals and many clinical laboratories do not provide sTfR testing. 1
  • When sTfR is unavailable, reticulocyte hemoglobin concentration (CHr) <30 pg can serve as an alternative predictor of response to intravenous iron. 2

Diagnostic Performance

  • Sensitivity and specificity for iron deficiency anemia are both 85.6-100% depending on the assay method used. 6, 4
  • Different measurement methods (chemiluminescent, immunoturbidimetric, immunonephelometric) have markedly different cutoff points (2.48-6.70 mg/L), which must be considered when interpreting results. 6
  • Area under the ROC curve ranges from 0.936-0.944, indicating excellent diagnostic accuracy. 6

When sTfR Does NOT Change Management

  • In premenopausal women with non-anemic iron deficiency (ferritin low but hemoglobin normal), GI investigation is generally not warranted as menstrual blood loss is the likely cause—sTfR adds little value here. 1
  • When ferritin is <15 μg/L in the absence of inflammation, iron deficiency is confirmed without needing sTfR. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.